logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure GPS-8. Trends in last year use of amphetamines among young adults (aged 15 to 34), measured by population surveys


Sample sizes (respondents) for the 15 to 34 age group for each country and year are presented in Table GPS-4.

Data taken from national surveys available in each country. Figures and methodology for each survey can be consulted in Table GPS-4 in the 2007 statistical bulletin.

For young adults, the EMCDDA uses the range 15 to 34 years (Denmark and UK from 16, Germany, Estonia (1998) and Hungary from 18). In France the age range was 25 to 34 in 1992 and 18 to 39 in 1995.


SB2006: Figure GPS-6.

See also Table GPS-0.

See also 'General notes for interpreting data' on the Explanatory notes and help page.


Reitox national reports 2006, taken from population surveys, reports or scientific articles.

Page last updated: Friday, 23 November 2007